Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antiviral therapy in adults with HIV, hepatitis C, and tuberculosis coinfection
ChiCTR-TRC-09000407Phase 4Completed
- Sponsor
- Guangzhou Eighth People's Hospital
- Start
- Oct 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of peginterferon alfa-2a and ribavirin in human immunodeficiency virus infection (HIV), hepatitis C virus infection and Tuberculosis (TB) (4 arms), sponsored by Guangzhou Eighth People's Hospital. Primary endpoints: AST and HCV RNA. Started Oct 2008; status: completed.
02
Drugs
peginterferon alfa-2aribavirin
03
Conditions
human immunodeficiency virus infection (HIV)hepatitis C virus infectionTuberculosis (TB)
Beyond the preview
Go deeper on ChiCTR-TRC-09000407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000407.